Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark FitzGerald

Showing results (31-40 of 325) with videos related to

Pageof 33
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2006
A framework for achieving better asthma control: introducing two new series in the journalMoira Chan-Yeung, J Mark FitzGerald
The New England Journal of Medicine|October 22, 2004
Case 22-2004: a 30-year-old woman with a pericardial effusionVictoria J Cook, J Mark FitzGerald
Expert Review of Clinical Pharmacology|July 5, 2018
Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotypeKhalid Al Efraij, J Mark FitzGerald
The European Respiratory Journal|October 7, 2017
Crowdfunding for respiratory research: a new frontier for patient and public engagement?Darrin P Wiebe, J Mark FitzGerald
Thorax|September 1, 2010
Asthma: improved understanding and insights into the challenges of achieving asthma controlG Ian Town, J Mark Fitzgerald
Expert Opinion on Emerging Drugs|August 24, 2017
Emerging interleukin receptor antagonists for the treatment of asthmaKhalid Al Efraij, J Mark FitzGerald
BMJ Open|February 5, 2015
Assessing beliefs and risk perceptions on smoking and smoking cessation in immigrant Chinese adult smokers residing in Vancouver, Canada: a cross-sectional studyJ Mark FitzGerald, Iraj Poureslami, Jessica Shum
Clinical Evidence|January 18, 2005
AsthmaRodolfo Dennis, Ivan Solarte, J Mark Fitzgerald
Cost Effectiveness and Resource Allocation : C/E|February 10, 2018
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in USZafar Zafari, Mohsen Sadatsafavi, J Mark FitzGerald, et al.
Clinical Evidence|April 20, 2006
AsthmaRodolfo Dennis, Ivan Solarte, J Mark Fitzgerald
Pageof 33

Showing results (31-40 of 325) with videos related to

Sort By:
Pageof 33
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 28, 2006
A framework for achieving better asthma control: introducing two new series in the journalMoira Chan-Yeung, J Mark FitzGerald
The New England Journal of Medicine|October 22, 2004
Case 22-2004: a 30-year-old woman with a pericardial effusionVictoria J Cook, J Mark FitzGerald
Expert Review of Clinical Pharmacology|July 5, 2018
Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotypeKhalid Al Efraij, J Mark FitzGerald
The European Respiratory Journal|October 7, 2017
Crowdfunding for respiratory research: a new frontier for patient and public engagement?Darrin P Wiebe, J Mark FitzGerald
Thorax|September 1, 2010
Asthma: improved understanding and insights into the challenges of achieving asthma controlG Ian Town, J Mark Fitzgerald
Expert Opinion on Emerging Drugs|August 24, 2017
Emerging interleukin receptor antagonists for the treatment of asthmaKhalid Al Efraij, J Mark FitzGerald
BMJ Open|February 5, 2015
Assessing beliefs and risk perceptions on smoking and smoking cessation in immigrant Chinese adult smokers residing in Vancouver, Canada: a cross-sectional studyJ Mark FitzGerald, Iraj Poureslami, Jessica Shum
Clinical Evidence|January 18, 2005
AsthmaRodolfo Dennis, Ivan Solarte, J Mark Fitzgerald
Cost Effectiveness and Resource Allocation : C/E|February 10, 2018
Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in USZafar Zafari, Mohsen Sadatsafavi, J Mark FitzGerald, et al.
Clinical Evidence|April 20, 2006
AsthmaRodolfo Dennis, Ivan Solarte, J Mark Fitzgerald
Pageof 33